{
  "id": "894ec2642747d443",
  "title": "Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U . S . Phase III FDA Trial",
  "description": "20260204T174500Z",
  "content": "",
  "source": "torontotelegraph.com",
  "source_url": "http://www.torontotelegraph.com/news/278848609/regentis-biomaterials-appoints-ori-gon-as-chief-financial-officer-and-chief-business-officer-as-gelrinc-progresses-towards-commercial-launch-in-europe-and-advances-in-us-phase-iii-fda-trial",
  "published_at": "20260204T174500Z",
  "fetched_at": "2026-02-05T00:29:17.336486+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Canada",
  "raw_data": {
    "url": "http://www.torontotelegraph.com/news/278848609/regentis-biomaterials-appoints-ori-gon-as-chief-financial-officer-and-chief-business-officer-as-gelrinc-progresses-towards-commercial-launch-in-europe-and-advances-in-us-phase-iii-fda-trial",
    "url_mobile": "",
    "title": "Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U . S . Phase III FDA Trial",
    "seendate": "20260204T174500Z",
    "socialimage": "",
    "domain": "torontotelegraph.com",
    "language": "English",
    "sourcecountry": "Canada"
  }
}